Top 20 of Liver Neoplasms

Article title # Publications/# Citations

Sorafenib in advanced hepatocellular carcinoma.

2008: SHARP Investigators Study Group; JFBlanc; LBolondi; IBorbath; JBruix; ACde Oliveira; AForner; PRGalle; ... EGane; TGiannaris; TFGreten; DHäussinger; PHilgard; JMLlovet; VMazzaferro; MMoscovici; CPorta; JLRaoul; SRicci; ASantoro; MSchwartz; JFSeitz; MShan; DVoliotis; SZeuzem;

794

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

2005: RBartenschlager; TDate; AHabermann; TKato; HGKräusslich; TJLiang; MMiyamoto; MMizokami; ... KMurthy; TPietschmann; TWakita; ZZhao;

769

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

1999: RBartenschlager; UHerian; JKoch; FKörner; VLohmann; LTheilmann;

647

Nuclear factor-kappaB in cancer development and progression.

2006: MKarin;

600

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

2007: HBEl-Serag; KLRudolph;

559

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.

1996: FAgani; JAForsythe; NVIyer; BHJiang; RDKoos; SWLeung; GLSemenza;

528

Management of hepatocellular carcinoma.

2005: Practice Guidelines Committee, American Association for the Study of Liver Diseases; JBruix; MSherman;

517

Hepatocellular carcinoma.

2003: JBruix; ABurroughs; JMLlovet;

442

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

2007: CCordon-Cardo; RADickins; EHernando; VKrizhanovsky; SWLowe; CMiething; WXue; LZender;

431

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.

2007: KGhoshal; RHenson; STJacob; FMeng; TPatel; HWehbe-Janek;

406

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

1996: MAmmatuna; SAndreola; FBozzetti; RDoci; LGennari; VMazzaferro; FMontalto; AMorabito; APulvirenti; ERegalia;

388

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

2001: EASL Panel of Experts on HCC; MBeaugrand; JBruix; AKBurroughs; EChristensen; MColombo; RLencioni; JMLlovet; ... LPagliaro; JRodés; MSherman;

376

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

1980: DPAden; CCHowe; BBKnowles;

357

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

2002: KJBlight; JAMcKeating; CMRice;

342

Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

1982: KMiyano; HNakabayashi; JSato; KTaketa; TYamane;

335

Management of hepatocellular carcinoma: an update.

2011: American Association for the Study of Liver Diseases; JBruix; MSherman;

331

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

1981: RPBeasley; CSChien; LYHwang; CCLin;

313

Rising incidence of hepatocellular carcinoma in the United States.

1999: HBEl-Serag; ACMason;

305

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

2009: TCChang; RRChivukula; KRClark; HWHwang; JKota; JRMendell; JTMendell; CLMontgomery; ... KAO'Donnell; MTorbenson; PVivekanandan; EAWentzel;

300

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

2008: KBurock; ZChen; ALCheng; JFeng; ZGuan; YKKang; JSKim; HLiang; ... JLiu; RLuo; HPan; SQin; YSun; WYTak; CJTsao; DVoliotis; JWang; JXu; TSYang; SYe; JZou;

295